XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Disaggregation of Income Statement Expenses
This following table presents segment operation results for the three and six months ended June 30, 2025 and 2024:
Three Months Ended
June 30,		Six Months Ended
June 30,
2025202420252024
Operating expenses:
Research and development - external costs (1)
$144,730 $101,769 $248,535 $171,406 
Research and development - internal costs (2)
49,449 29,738 93,778 54,688 
General and administrative
32,040 21,474 64,699 41,359 
Total operating expenses
$226,219 $152,981 $407,012 $267,453 
Total other income, net
$59,646 $24,278 $99,721 $43,730 
Net loss
$166,573 $128,703 $307,291 $223,723 
____________________________________________________________
(1)Research and development - external costs consist of product manufacturing costs, clinical costs, research and development consumables, lab supplies and equipment, facility and allocated costs, and other external costs.
(2)Research and development - internal costs consist of internal employee costs including stock-based compensation expenses.